Physician profile
Gregory M Bailey
NPI 1639245210
$1,056,342.43
in general payments reported to CMS, 2019-2025
26 companies · $307K in 2025
The $307K reported for 2025 was more than what 97% of Orthopaedic Surgery of The Spine providers received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $208K · 2020: $191K · 2021: $63K · 2022: $79K · 2023: $96K · 2024: $112K · 2025: $307K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $483K · Consulting Fee: $14K · Travel and Lodging: $10K · Food and Beverage: $4,779 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,936 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $790.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $482,940.81 |
| Consulting Fee | $14,250.00 |
| Travel and Lodging | $10,217.00 |
| Food and Beverage | $4,778.91 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,935.50 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $790.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| The Institute of Musculoskeletal Science and Education | $437,666.37 | 2019-2025 | Spira, Orthros, Siconus |
| Philadelphia Medical Management Company LLC | $188,672.08 | 2019-2020 | |
| Camber Spine Technologies LLC | $152,085.20 | 2019-2025 | |
| Medtronic, INC. | $132,136.64 | 2021-2025 | Inceptiv, Intellis Adaptivestim |
| Globus Medical, INC. | $86,147.06 | 2019-2025 | Vyrsa V1, Fortify / Fortify-I, Fortify |
| Medicrea USA, Corp. | $33,697.85 | 2019-2020 | |
| Interventional Pain Technologies INC. | $20,857.19 | 2022-2023 | Vyrsa V1 |
| Nevro Corp. | $1,094.71 | 2022-2024 | Senza |
| Cerapedics INC. | $804.08 | 2022-2023 | I-Factor Peptide Enhanced Bone Graft |
| Boston Scientific Corporation | $680.87 | 2023-2025 | General - Pain Management, Intracept Rf Probe, Intracept |
| Stryker Corporation | $391.30 | 2021 | |
| Medtronic USA, INC. | $312.54 | 2019-2020 | |
| Ethicon US, LLC | $272.91 | 2020-2024 | Monocryl, Harmonic, Ethicon |
| Abbott Laboratories | $258.38 | 2022-2023 | Proclaim |
| Innovation Technologies INC | $214.19 | 2023-2025 | Irrisept |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spinal Elements, INC. | $207.58 | 2025 | |
| Kuros Biosciences USA, INC | $197.01 | 2024 | Magnetos |
| Spineart USA INC | $178.11 | 2023 | Perla Tl |
| Ossdsign USA Incorporated | $168.83 | 2024-2025 | Ossdsign Catalyst |
| Medical Device Business Services, INC. | $99.99 | 2023 | |
| Highridge Medical LLC | $71.00 | 2024 | Mobi-C Plug & Fit US |
| Zimvie INC. | $47.75 | 2022 | |
| Surgalign Spine Technologies, INC. | $27.65 | 2021 | |
| Organogenesis INC. | $22.98 | 2023 | Puraply |
| Prescient Lab Services, LLC | $16.83 | 2025 | Avertd Intellipac Reagent Module, Avertd Biofilmchip Microarray Magazine, Avertd Amplification Mix |
| Depuy Synthes Sales INC. | $13.33 | 2024 | Monovisc, Orthovisc |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$100,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Bailey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.